Topchoice Medical Co., Inc. (SHA:600763)
China · Delayed Price · Currency is CNY 36.79
-0.09 (-0.24%)
Aug 3, 2026, 3:00 PM CST
Topchoice Medical Co. Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,924 | 2,913 | 2,874 | 2,847 | 2,719 | 2,781 |
Revenue Growth | 0.47% | 1.37% | 0.96% | 4.70% | -2.23% | 33.18% |
Gross Profit Gross Profit Growth | 1,127 | 1,125 | 1,107 | 1,097 | 1,110 | 1,281 |
Operating Income Operating Income Growth | 694.42 | 693.72 | 690.92 | 694.35 | 734.97 | 929.37 |
Net Income Net Income Growth | 504.99 | 501.95 | 501 | 500.44 | 548.27 | 702.81 |
Earnings Per Share EPS Growth | 1.12 | 1.12 | 1.12 | 1.12 | 1.22 | 1.56 |
EPS Growth | -1.66% | 0% | 0% | -8.26% | -21.92% | 42.21% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Intersegment elimination Intersegment elimination Growth | -229.11 | -213.86 | -174.96 | -204.21 | - |
Sales Products Sales Products Growth | 231.11 | 133.38 | 167.34 | 192.28 | 125.28 |
Management Services and Others Management Services and Others Growth | 126.63 | 194.7 | 145.06 | 137.99 | 0.79 |
Medical Services Medical Services Growth | 2,784 | 2,760 | 2,709 | 2,593 | 2,632 |
Total Total Growth | 2,913 | 2,874 | 2,847 | 2,719 | 2,758 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 794.34 | 698.64 | 621.98 | 594.48 | 630.32 | 843.99 |
Total Debt Total Debt Growth | 1,147 | 1,112 | 1,445 | 1,459 | 1,154 | 1,299 |
Net Cash (Debt) Net Cash Growth | -352.3 | -413.56 | -822.56 | -864.77 | -523.63 | -455.02 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.78 | -0.92 | -1.84 | -1.94 | -1.17 | -1.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 824.1 | 810.72 | 762.99 | 841.02 | 670.05 | 939.41 |
Capital Expenditures CapEx Growth | -236.15 | -246.2 | -332.11 | -508.9 | -421.53 | -367.32 |
Free Cash Flow Free Cash Flow Growth | 587.96 | 564.52 | 430.88 | 332.13 | 248.52 | 572.09 |
Free Cash Flow Growth | 14.15% | 31.02% | 29.73% | 33.64% | -56.56% | 6.33% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.56% | 38.63% | 38.51% | 38.53% | 40.81% | 46.06% |
Operating Margin | 23.75% | 23.81% | 24.04% | 24.39% | 27.03% | 33.42% |
Pretax Margin | 24.19% | 24.21% | 24.14% | 24.90% | 27.15% | 35.05% |
Profit Margin | 17.27% | 17.23% | 17.43% | 17.58% | 20.17% | 25.27% |
FCF Margin | 20.11% | 19.38% | 14.99% | 11.67% | 9.14% | 20.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.450 | - | 0.450 | 0.311 |
Dividend Per Share Growth | - | - | 44.70% | - |
Dividend Yield | 1.22% | - | 1.03% | 0.58% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 32.87 | 35.83 | 39.64 | 48.98 | 89.47 | 90.79 |
Forward PE | 30.66 | 37.43 | 46.14 | 29.21 | 76.15 | 75.61 |
P/FCF Ratio | 28.06 | 31.86 | 46.09 | 73.81 | 197.39 | 111.53 |
PS Ratio | 5.64 | 6.17 | 6.91 | 8.61 | 18.04 | 22.95 |